0001161697-24-000023.txt : 20240103
0001161697-24-000023.hdr.sgml : 20240103
20240103171847
ACCESSION NUMBER: 0001161697-24-000023
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240101
FILED AS OF DATE: 20240103
DATE AS OF CHANGE: 20240103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kalb Michael Wayne
CENTRAL INDEX KEY: 0001678248
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 24508174
MAIL ADDRESS:
STREET 1: 24 LUCILLE LANE
CITY: DIX HILLS
STATE: NY
ZIP: 11746
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
3
1
form_3.xml
FORM 3 FOR 01-01-2024
X0206
3
2024-01-01
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001678248
Kalb Michael Wayne
355 ALHAMBRA CIRCLE
SUITE 801
CORAL GABLES
FL
33134
0
1
0
0
Executive Vice President & CFO
Common Stock, par value $0.001 per share
0
D
Options to purchase common stock
16.81
2031-01-01
Common Stock
257214
D
Restricted Stock Units
Common Stock
35693
D
Derivative Securities vest in five annual tranches beginning on January 1, 2025.
Shares of common stock will be delivered to the Reporting Person upon vesting.
Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
/s/ Michael W. Kalb
2024-01-03